HC Wainwright & Co. Maintains Buy on Aura Biosciences, Lowers Price Target to $18
Aura Biosciences Inc
Aura Biosciences Inc AURA | 0.00 |
HC Wainwright & Co. analyst Andres Y. Maldonado maintains Aura Biosciences (NASDAQ:
AURA) with a Buy and lowers the price target from $24 to $18.
